Stay updated on Ziftomenib in AML Clinical Trial
Sign up to get notified when there's something new on the Ziftomenib in AML Clinical Trial page.

Latest updates to the Ziftomenib in AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe study record advances to a new version (v3.5.4) with an 'Active, not recruiting' status and updated Study Status, Recruitment Status, and Contacts/Locations, replacing the previous 'Recruiting' state from v3.5.3.SummaryDifference0.4%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe history now includes a new revision entry, v3.5.3, and the previous revision, v3.5.2, is removed from the current history. This reflects an update to the study record's revision metadata rather than substantive changes to trial data.SummaryDifference0.0%

- Check34 days agoChange DetectedThe record history shows an additional later update (2026-04-21) with changes limited to Study Status and Contacts/Locations. Another older entry is reflected as removed (2025-11-10), but no substantive study details are indicated as changing.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page footer now displays Revision: v3.5.2, replacing v3.5.0.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the page history.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision: v3.4.3 has been added as the latest update, replacing the previous v3.4.2 entry.SummaryDifference0.0%

Stay in the know with updates to Ziftomenib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ziftomenib in AML Clinical Trial page.